Abbott SARS-Cov-2 Antibody Test Had 100% Sensitivity in Study

Abbott said that new research, published in the Journal of Clinical Microbiology found that its SARS-CoV-2 IgG lab-based serology blood test had 99.9% specificity and 100% sensitivity for detecting the IgG antibody in patients 17 days or more after symptoms began

Independent research was conducted by University of Washington School of Medicine in Seattle

To view the source of this information click here

To contact the reporter on this story:
Sonali Pathirana in New York at spathirana@bloomberg.net

To contact the editor responsible for this story:
Stephen Foxwell at sfoxwell@bloomberg.net

To read the full article log in.

Learn more about a Bloomberg Law subscription.